Navigation Links
Genethon and Children's Hospital Boston Get FDA approval for a Wiskott Aldrich Gene Therapy Trial
Date:7/21/2011

f Translational Research for Children's Hospital Boston, will serve as sponsor-investigator. The gene insertion of patient cells will be accomplished in the Connell O'Reilly Family Good Manufacturing facility at the Dana-Farber Cancer Institute in collaboration with the Center for Human Cell Therapy at Harvard Medical School.

Wiskott Aldrich Syndrome (WAS) is a rare primary immune deficiency disease causing significant bleeding due to low platelet count and increased incidence of serious infections.  Most patients have mild to severe eczema and are also at a higher risk of developing autoimmune disorders and malignancies such as lymphoma.  The forthcoming clinical trial results from a research program initiated in 2002 by the group of Anne Galy at Genethon (Inserm UMR951/Genethon, Universite d'Evry Val d'Essonne, EPHE), which has developed an ex vivo approach that uses an HIV-derived lentiviral vector to transfer genes into autologous CD34+ hematopoietic stem cells from WAS patients.

"This authorization constitutes a new key stage for the project WAS initiated in 2002 by Anne Galy and her team at the Genethon. It is also an international recognition of the quality of the work of Genethon. Without the donations collected during the French Telethon, this international gene therapy trial could not exist," states Laurence Tiennot-Herment, Chairperson, AFM and Genethon. 

"We are very happy with the approval given by the FDA for the extension of the WAS clinical trial by the group headed by Prof. Williams. It demonstrates again the ability of Genethon to bring its research projects to the clinic in collaboration with the best clinical teams worldwide, for the benefit of patients. It reflects our cutting edge expertise in the field of translational research, bioproduction and preparation and implementation of clinical trials," emphasizes Frederic Revah, CEO Genethon.

"At Children's Hospital Boston,
'/>"/>

SOURCE Children's Hospital Boston
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Pradaxa® (dabigatran etexilate mesylate) Capsules Now on Formulary at Nations Top Heart Hospitals
2. Axial Biotech Signs Agreement With Shriners Hospital for Children
3. Texas Childrens Hospital is First Pediatric Hospital in the Nation to Implant Artificial Heart
4. Paoli Hospital Pioneers New Treatment for Uterine Fibroids and Malformations
5. Baylor College of Medicine and Texas Childrens Hospital Neuroscientist Dr. Huda Zoghbi Awarded Gruber Neuroscience Prize
6. Hospital for Special Surgery to Host International Arthritis Summit: Frontiers in Osteoarthritis Research, Prevention and Care
7. St. Lukes Hospital & Health Network Selects CareTech Solutions to Provide Proactive Monitoring of Hospital IT Infrastructure
8. BioNeutral to Premier its EPA-Approved Ygiene® 206 Hospital-Grade Disinfectant at the Annual 2011 APIC Conference, While Community Health of South Florida Begins Product Review
9. SynapDx Corporation Licenses Autism Diagnostic Discoveries From Childrens Hospital Boston
10. Newly Published Study Shows Dramatic Reduction in Hospital Acquired Infections
11. WARFARIN Study Launched at WellStar Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Milpitas, Calif. (PRWEB) March 03, 2015 ... risk management excellence were honored by the Global ... annual event which took place on Wednesday, February 25th, ... , The GSCRC was formed to bring together supply ... thought leaders to advance the professional discipline through opportunities ...
(Date:3/3/2015)... March 3, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... scientific journal, Expert Opinion on Biological Therapy , ... Zhenggang Zhang , at the Henry Ford Hospital ... Thymosin beta 4 (TB4) has the capacity to promote ... or more post-injury, leading to neurological recovery in each ...
(Date:3/3/2015)... , March 3, 2015  Rosa & Co. ... drug-disease modeling and simulation research, today announced it has ... American Society for Clinical Pharmacology and Therapeutics meeting in ... 2015.   Logo - http://photos.prnewswire.com/prnh/20150302/179058LOGO   ... will present a poster describing a quantitative systems pharmacology ...
(Date:3/3/2015)... , March 3, 2015 Kindred Biosciences, Inc. (NASDAQ: ... and improving the lives of pets, announced today that it ... on March 12, 2015 after the market close. The Company ... that day. Interested parties may access the ... (484) 756-4262 internationally, and using conference ID 98449349.  ...
Breaking Biology Technology:Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3
... HUBBARD, Ohio, Jan. 10, 2012   NanoLogix Inc. (PINK ... antibiotic sensitivity determination of live bacteria announces that has instructed ... submittal to the US FDA . The applications are ... for approval for use as a BSL-3 test process for ...
... and BEIJING, Jan. 10, 2012 The global fight ... Aeras and the China National Biotec Group (CNBG) announce ... new tuberculosis (TB) vaccines. The agreement between the leading ... biotechnology corporation in China signals a commitment by both ...
... in Spanish . Miguel A. Cazalilla, ... the Donostia International Physics Center (DIPC), together with other four ... was recently invited to write a review article that has ... Modern Physics of the American Physical Society, where only ...
Cached Biology Technology:NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents 2NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents 3NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents 4Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D 2Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D 3Smaller and more powerful electronics requires the understanding of 'quantum jamming' physics 2
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
(Date:2/5/2015)... SAN FRANCISCO , January 28, 2015 ... Camera Market Analysis, Size And Segment Forecasts To 2020 ... The global IR camera market is expected to reach ... study by Grand View Research, Inc. IR cameras help ... injuries, and are expected to witness surging demand in ...
(Date:2/5/2015)... , Feb. 3, 2015 Despite ... demand from industries such as consumer electronics, automotive, ... for surface mount technology (SMT) screen printers. Innovations ... automatic control will push the adoption curve up. ... remain steady as glue dispensers are indispensable in ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3
... responsible for the plague and some forms of food poisoning ... way, according to a new study in the September 8, ... , The researchers found that these bacteria, which belong to ... unrelated mammalian enzyme. That copycat protein blocks host cells' capacity ...
... yeast, University of Wisconsin-Madison researchers have uncovered novel functions of ... master regulatory switch -- a control that determines gene activity ... neurological disorders. , The work, published in the Dec. 8 ... in a single gene can have widespread effects on regulation ...
... Proteins called H2AX act as "first aid" to DNA, among ... world's most powerful light microscope (the only one of ... is distributed in the cell nucleus: in clusters, directing the ... it is really needed. , Many biological processes lie ...
Cached Biology News:Study illuminates how the plague bacteria causes disease 2Study illuminates how the plague bacteria causes disease 3From a lowly yeast, researchers divine a clue to human disease 2Nanoscale microscope sheds first light on gene repair 2
Request Info...
Request Info...
Loading Buffer...
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, Xylene Cyanol, glycerol solution in TE...
Biology Products: